<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03039426</url>
  </required_header>
  <id_info>
    <org_study_id>RJBUPI</org_study_id>
    <nct_id>NCT03039426</nct_id>
  </id_info>
  <brief_title>Postoperative Cesarean Delivery Pain Relief; Diclofenac Versus Bupivacaine</brief_title>
  <official_title>A Randomized Comparison of Bupivacaine Peritoneal and Subcutaneous Infiltration Versus Diclofenac Intramuscular Injection for Postoperative Pain Relief in Patient Undergoing Cesarean Delivery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rajavithi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rajavithi Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized controlled trial, compared postoperative pain score in patient undergoing
      cesarean delivery between bupivacaine peritoneal and subcutaneous infiltration and diclofenac
      intramuscular injection
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Postoperative cesarean delivery was painful that can effect daily activity, resulted in poor
      quality of life and required morphine injection to relief pain which had both maternal and
      breastfeeding infancy side effect. So this study compare efficacy of diclofenac and
      bupivacaine by measured the pain score and requirement of morphine injection.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Actual">June 30, 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compared pain score change from baseline at 2, 6 and 24 hours at post-operation between 2 groups by visual analogue scale</measure>
    <time_frame>2, 6 and 24 hours post-operation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Compared rescued dose of morphine injection</measure>
    <time_frame>Within 24 hours post-operation</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Cesarean Delivery</condition>
  <arm_group>
    <arm_group_label>Group Bupivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.5% bupivacaine 20ml divided in two; 10 ml intraperitoneal infiltration and 10 ml subcutaneous infiltration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group Diclofenac</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>diclofenac 75 mg intramuscular, 2 hours postoperation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>0.5% bupivacaine 20ml divided in two; 10 ml intraperitoneal infiltration and 10 ml subcutaneous infiltration</description>
    <arm_group_label>Group Bupivacaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diclofenac</intervention_name>
    <description>diclofenac 75 mg intramuscular, 2 hours postoperation</description>
    <arm_group_label>Group Diclofenac</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergo elective or urgency cesarean delivery at Rajavithi Hospital in
             2016-2017

               -  Urgency conditions: CPD, fail induction of labor, antepartum hemorrhage without
                  hypovolemic shock, dystocia, previous cesarean section and active labor,
                  malpresentation in labor, macrosomic presentation in labor

          -  Pregnant women more than 20 years of age

          -  Gestational age more than 37 week

          -  Cesarean section under regional or general anesthesia

          -  Ability to communicating, writing and reading Thai language

        Exclusion Criteria:

          -  Inability to communicating or writing or reading Thai language

          -  Contraindicated to bupivacaine or diclofenac or morphine

          -  Pregnant women with emergency conditions

          -  Have one or more complication of pregnancy

          -  Intraoperative arrhythmia

          -  Pregnant women less than 20 years of age

          -  Regional anesthesia with morphine
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Natthida Mekwongtrakarn</name>
      <address>
        <city>Bangkok</city>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Natthida Mekwongtrakarn, MD</last_name>
      <phone>+66812588470</phone>
      <email>m_natthida@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Suphet Tuipae, MD</last_name>
      <phone>+66812588470</phone>
      <email>m_natthida@hotmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Rajavithi Hospital</name>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rajavithi Hospital</last_name>
      <phone>+6623548108</phone>
      <email>m_natthida@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 28, 2016</study_first_submitted>
  <study_first_submitted_qc>January 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2017</study_first_posted>
  <last_update_submitted>October 8, 2017</last_update_submitted>
  <last_update_submitted_qc>October 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Diclofenac</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

